Let's STOP Now Trial: Smoking in Trauma Orthopaedic Patients

NCT02428244 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 269

Last updated 2019-09-12

No results posted yet for this study

Summary

It is well known that smoking has deleterious effects to fracture/broken bone outcomes. Complications associated with smoking can be mitigated by smoking cessation. Initiating smoking cessation programs while patients are in the inpatient hospital setting has shown to be an opportune time to enroll patients in a smoking cessation program. The goal of this study is to determine if inpatient smoking counseling with/without follow-up is superior to the standard smoking cessation information associated with admission to a hospital facility.

Conditions

  • Smoking, Tobacco
  • Fractures, Bone

Interventions

BEHAVIORAL

Motivational Interviewing

Motivational Interviewing coupled with education will be provided to help participants understand the risks associated with smoking and their fracture care. They will be referred to the quitline.

BEHAVIORAL

Motivational Interviewing + Follow-up

Motivational Interviewing coupled with education will be provided to help participants understand the risks associated with smoking and their fracture care. They will be referred to the quitline. In this intervention, the participants will receive additional motivational interviewing sessions at 2 weeks, 6 weeks, 3 months and 6 months.

Sponsors & Collaborators

  • Maryland Department of Health and Mental Hygiene

    collaborator OTHER_GOV
  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Paul E Matuszewski, MD · University of Maryland, Department of Orthopaedics

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2018-10-24
Completion
2019-04-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02428244 on ClinicalTrials.gov